Clinical Trials
9 trialsNCT06284226 2024-04-16
CCT-ANK-11
Beijing Kejing Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Withdrawn
NCT04870034 2023-12-22
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT05465590 2023-12-21
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer
Mainline Biosciences, Inc.
Phase EARLY_PHASE1 Withdrawn
NCT04186988 2022-02-01
[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy
University of California, Davis
Phase EARLY_PHASE1 Withdrawn
NCT04677361 2021-10-08
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
Fox Chase Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03574220 2020-04-07
Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT02419170 2016-07-18
Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)
Washington University School of Medicine
Phase EARLY_PHASE1 Withdrawn
NCT02277457 2016-06-24
Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT00606970 2013-05-07
Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy
New Hope Medical Center
Phase EARLY_PHASE1 Withdrawn